Abstract
Background
Malignant pleural mesothelioma (MPM) is an uncommon neoplasm. MPM occurs more frequently in patients born or living in certain villages of Turkey.
Objectives
We aimed to review radiological findings of MPM.
Patients and Methods
We reviewed the CT findings in 219 biopsy-proven MPM patients admitted to our clinic between 1993 and 2008.
Results
The most common CT findings included pleural thickening (n=197, 90%) classified as diffuse (n=138, 63%), nodular (n=49, 22%) and mass-type (n=16, 7%). Pleural effusion was found in 173 patients (79%), involvement of the interlobar fissures in 159 (73%), mediastinal pleural involvement in 170 (78%), volume contraction in 142 (65%), mediastinal shift in 102 (47%) and mediastinal lymphadenopathy in 54 (25%).
Conclusion
MPM may present with diverse radiological features. Pleural thickening and pleural effusion were the most frequent radiological findings. Thoracic CT scans might be assessed more cautiously in patients with environmental exposure to asbestos.
Keywords: Asbestos, Tomography, X-Ray Computed, Mesothelioma, Cystic, Thorax
1. Introduction
Malignant pleural mesothelioma (MPM) is an infrequent neoplasm (1). However, MPM is the most common primary malignancy of the pleura and its incidence is estimated as 2000-3000 cases per year in the United States of America (2, 3). MPM occurs frequently in patients from certain villages in the central and southeastern regions of Turkey compared to other parts of the country. Nowadays, thoracic computed tomography (CT) scan with contrast is a much more sensitive examination for diagnosing, staging and follow-up of patients with MPM (4-9). CT plays an important role in the assessment and diagnosis of these tumors and is superior to conventional chest radiography (10).
2. Objectives
In this study, we evaluated CT findings in 219 cases of MPM caused by environmental exposure to asbestos fibers.
3. Patients and Methods
We retrospectively reviewed the CT scans of patients with biopsy-proven MPM evaluated at our clinic between 1993 and 2008. All patients had a history of environmental asbestos exposure. All patients had a chest radiograph taken maximum two-weeks before computed tomography. Thoracic CT was performed in all subjects, using a Picker PQS (Cleveland, OH, USA) spiral CT scanner. Evaluation was carried out in chest images obtained in 10 mm slices from the apices of the lung to costophrenic angles. The sections were taken in the supine position at the end of the inspiration. Intravenous iodinated contrast medium was given to the patients to determine mediastinal pathologies. Patients were prospectively evaluated with CT scan and the sections were evaluated by a radiologist blind to pathological results, to give binary decisions. No rating scale was utilized. The diagnoses of malignant mesothelioma were confirmed pathologically in all cases. In most patients, the diagnosis of mesothelioma was made by closed pleural biopsy; in others, the diagnosis was reached through transthoracic biopsy, thoracoscopy, thoracotomy, cytologic examination, extrathoracic biopsy and pericardiectomy. The pleural thickening was classified as diffuse, mass type and nodular and the localization of pleural effusion as unilateral and bilateral. In cases of different types of pleural thickening in the same individual, each type was noted separately. Diffuse pleural thickening was demarcated as a pleural thickness of 10 mm or less, pleural nodules as focal pleural thickness of 10-30 mm and pleural masses as lesions of 30 mm or more in diameter. Involvement of interlobar fissures and mediastinal pleura were noted. The presence of calcified pleural plaques and hyaline pleural plaques on the contralateral pleura was also assessed. Hyaline pleural plaques were defined as a focal increase in soft tissue density along the pleura, which is well demarcated and clearly separated from the lung. Dislocation of the mediastinal structures was defined as “mediastinal shift”. The volume loss of hemithorax was defined as volume contraction. If mediastinal lymph nodes were greater than 10 mm, they were considered as pathological. Both hemithoraces were evaluated for pulmonary parenchymal abnormalities such as tumoral invasion or fibrosis and presence of calcified pleural plaques. All these findings were recorded for both males and females (11-15).
4. Results
The study included 219 malignant pleural mesothelioma patients (129 men and 90 women). The mean age of the patients was 58.3 ± 12.6 years, with a range of 18-85 years. Nearly half of these patients were coming from Yildizeli, a town in Sivas and the villages around this town where the risk of environmental exposure to asbestos is high. The rest of the patients were mainly residents of Sivas and surrounding cities. Eighty-two patients (37.4%) were current smokers; the others included former, passive, and never smokers. The average of cigarette smoking history among all smokers was 27.93 ± 21.59 pack-years. The results are presented in Tables 1 and 2.
Table 1. CT Findings in 219 Patients with MPM.
| Male | Female | Total, No. (%) | |
|---|---|---|---|
| Pleural Thickening | |||
| Diffuse | 81 | 57 | 138 (63.0) |
| Irregular | 30 | 15 | 45 (20.5) |
| Mass type | 48 | 36 | 84 (38.3) |
| Smooth | 28 | 21 | 49 (22.4) |
| Nodular | 10 | 6 | 16 (7.3) |
| Pleural Effusion | |||
| Unilateral | 94 | 74 | 168 (76.7) |
| Bilateral | 3 | 2 | 5 (2.3) |
| Interlobar Fissural Involvement | 95 | 64 | 159 (72.6) |
| Mediastinal Pleural Involvement | 96 | 74 | 170 (77.6) |
| Pleural Plaque | |||
| Hyaline | 21 | 11 | 32 (14.6) |
| Calcified | 3 | 3 | 6 (2.7) |
| Mediastinal shift | 59 | 43 | 102 (46.6) |
| Volume Contraction | 88 | 54 | 142 (64.8) |
| Mediastinal Lymphadenopathy | 35 | 19 | 54 (24.7) |
| Atelectasis | 28 | 17 | 45 (20.5) |
| Chest Wall Involvement | 20 | 15 | 35 (16.0) |
| Pneumothorax | 2 | 1 | 3 (1.4) |
| Parenchymal Abnormalities | 18 | 10 | 28(12.8) |
Table 2. Chest X-Ray Findings in 219 Patients with MPM.
| No. (%) | |
|---|---|
| Pleural Thickening | 105 (47.9) |
| Pleural Effusion | 146 (66.7) |
| Volume Contraction | 94 (42.9) |
| Mediastinal Shift | 70 (32.0) |
| Pleural Calcifications | 24 (11.0) |
| Thickening of Interlobar Fissure | 26 (11.9) |
| Pneumothorax | 3 (1.4) |
5. Discussion
CT plays an important role in the diagnosis and assessment of patients with mesothelioma. Pleural thickening and pleural effusion are the most encountered features. Although some findings are quite characteristic, none is pathognomonic for the disease. Nevertheless, CT remains to be the dominant modality for assessing patients with mesothelioma, including evaluation of treatment response. CT findings can delineate the optimal site for biopsy, while providing a tremendous amount of anatomic information about the stage of the disease (16-20).
Acknowledgments
None declared.
Footnotes
Implication for health policy/practice/research/medical education: This report provides an overview on the main computed tomography findings of malignant mesothelioma, which will help clinicians recall this diagnosis especially in endemic regions.
Please cite this paper as: Tamer Dogan O, Salk I, Tas F, Epozturk K, Gumus C, Akkurt I, et al. Thoracic Computed Tomography Findings in Malignant Mesothelioma. Iran J Radiol. 2012; 9 (4): 209-11. DOI: 10.5812/iranjradiol.8764
Authors’ Contribution: Study concept and design: Dogan, Salk and Tas; analysis and interpretation of data: Dogan, Salk and Gumus; drafting of the manuscript: Dogan and Epozturk; Intellectual content: Akkurt and Ozsahin; Statistical analysis: Ozsahin.
Financial Disclosure: None declared.
Funding/Support: No funding was received for the research on which this article is based.
References
- 1.Metintas M, Ucgun I, Elbek O, Erginel S, Metintas S, Kolsuz M, et al. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol. 2002;41(1):1–9. doi: 10.1016/S0720-048X(01)00426-0. [DOI] [PubMed] [Google Scholar]
- 2.Ng CS, Munden RF, Libshitz HI. Malignant pleural mesothelioma: the spectrum of manifestations on CT in 70 cases. Clin Radiol. 1999;54(7):415–21. doi: 10.1016/S0009-9260(99)90824-3. [DOI] [PubMed] [Google Scholar]
- 3.Miller BH, Rosado-de-Christenson ML, Mason AC, Fleming MV, White CC, rasna MJ. From the archives of the AFIP. Malignant pleural mesothelioma: radiologic-pathologic correlation. Radiographics. 1996;16(3):613–44. doi: 10.1148/radiographics.16.3.8897628. [DOI] [PubMed] [Google Scholar]
- 4.Sahin AA, Coplu L, Selcuk ZT, Eryilmaz M, Emri S, Akhan O, et al. Malignant pleural mesothelioma caused by environmental exposure to asbestos or erionite in rural Turkey: CT findings in 84 patients. AJR Am J Roentgenol. 1993;161(3):533–7. doi: 10.2214/ajr.161.3.8394641. [DOI] [PubMed] [Google Scholar]
- 5.Baris YI, Bilir N, Artvinli M, Sahin AA, Kalyoncu F, Sebastien P. An epidemiological study in an Anatolian village environmentally exposed to tremolite asbestos. Br J Ind Med. 1988;45(12):838–40. doi: 10.1136/oem.45.12.838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Baris YI, Saracci R, Simonato L, Skidmore JW, Artvinli M. Malignant mesothelioma and radiological chest abnormalities in two villages in Central Turkey. An epidemiological and environmental investigation. Lancet. 1981;1(8227):984–7. doi: 10.1016/S0140-6736(81)91742-6. [DOI] [PubMed] [Google Scholar]
- 7.Senyigit A, Bayram H, Babayigit C, Topcu F, Nazaroglu H, Bilici A, et al. Malignant pleural mesothelioma caused by environmental exposure to asbestos in the Southeast of Turkey: CT findings in 117 patients. Respiration. 2000;67(6):615–22. doi: 10.1159/000056290. [DOI] [PubMed] [Google Scholar]
- 8.Topcu F, Bayram H, Simsek M, Kaya K, Ozcan C, Isik R, et al. High-resolution computed tomography in cases with environmental exposure to asbestos in Turkey. Respiration. 2000;67(2):139–45. doi: 10.1159/000029501. [DOI] [PubMed] [Google Scholar]
- 9.Dogan M. Sources and types of mineral dust in regions of Turkey with endemic malignant mesothelioma. Indoor Built Environ. 2003;12:377–83. doi: 10.1177/1420326X03038960. [DOI] [Google Scholar]
- 10.Rabinowitz JG, Efremidis SC, Cohen B, Dan S, Efremidis A, Chahinian AP, et al. A comparative study of mesothelioma and asbestosis using computed tomography and conventional chest radiography. Radiology. 1982;144(3):453–60. doi: 10.1148/radiology.144.3.7100456. [DOI] [PubMed] [Google Scholar]
- 11.Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353(15):1591–603. doi: 10.1056/NEJMra050152. [DOI] [PubMed] [Google Scholar]
- 12.Morinaga K, Kishimoto T, Sakatani M, Akira M, Yokoyama K, Sera Y. Asbestos-related lung cancer and mesothelioma in Japan. Ind Health. 2001;39(2):65–74. doi: 10.2486/indhealth.39.65. [DOI] [PubMed] [Google Scholar]
- 13.Pelin K, Hirvonen A, Linnainmaa K. Expression of cell adhesion molecules and connexins in gap junctional intercellular communication deficient human mesothelioma tumour cell lines and communication competent primary mesothelial cells. Carcinogenesis. 1994;15(11):2673–5. doi: 10.1093/carcin/15.11.2673. [DOI] [PubMed] [Google Scholar]
- 14.Price B. Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol. 1997;145(3):211–8. doi: 10.1093/oxfordjournals.aje.a009093. [DOI] [PubMed] [Google Scholar]
- 15.Price B, Ware A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol. 2004;159(2):107–12. doi: 10.1093/aje/kwh025. [DOI] [PubMed] [Google Scholar]
- 16.Roushdy-Hammady I, Siegel J, Emri S, Testa JR, Carbone M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet. 2001;357(9254):444–5. doi: 10.1016/S0140-6736(00)04013-7. [DOI] [PubMed] [Google Scholar]
- 17.Beauchamp HD, Kundra NK, Aranson R, Chong F, MacDonnell KF. The role of closed pleural needle biopsy in the diagnosis of malignant mesothelioma of the pleura. Chest. 1992;102(4):1110–2. doi: 10.1378/chest.102.4.1110. [DOI] [PubMed] [Google Scholar]
- 18.Kawashima A, Libshitz HI. Malignant pleural mesothelioma: CT manifestations in 50 cases. AJR Am J Roentgenol. 1990;155(5):965–9. doi: 10.2214/ajr.155.5.2120965. [DOI] [PubMed] [Google Scholar]
- 19.Zielinski M, Hauer J, Hauer L, Pankowski J, Nabialek T, Szlubowski A. Staging algorithm for diffuse malignant pleural mesothelioma. Interact Cardiovasc Thorac Surg. 2010;10(2):185–9. doi: 10.1510/icvts.2009.213611. [DOI] [PubMed] [Google Scholar]
- 20.Fasola G, Belvedere O, Aita M, Zanin T, Follador A, Cassetti P, et al. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002). Oncologist. 2007;12(10):1215–24. doi: 10.1634/theoncologist.12-10-1215. [DOI] [PubMed] [Google Scholar]